AZYMAB

Welcome to the Brand page for “AZYMAB”, which is offered here for Scientific research and development of preparations, agents and technology for the development of antibody therapeutics for the treatment, and prophylaxis of human diseases, disorders and conditions, cancer, autoimmune and inflammatory diseases; the licensing of proprietary intellectual property; providing scientific information to scientists, physicians and health care providers.

Its status is currently believed to be active. Its class is “Miscellaneous”. “AZYMAB” is believed to be currently owned by “Zymeworks Inc.”

Owner:
ZYMEWORKS INC.
Owner Details
Description:
Scientific research and development of preparations, agents and technology for the development of antibody therapeutics for the treatment, and prophylaxis of human diseases, disorders and conditions, cancer, autoimmune and inflammatory diseases; the licensing of proprietary intellectual property; providing scientific information to scientists, physicians and health care providers
Categories: AUTOIMMUNE
  CANCER
  DEVELOPMENT
  HEALTH CARE PROVIDERS
  INFLAMMATORY DISEASES THE LICENSING
  PHYSICIANS
  SCIENTIFIC RESEARCH